Ukutholakala ukuthi unomdlavuza ngokuvamile kuvusa abantu ukuba benze isinyathelo futhi kubangele ukusinda okunamandla okuphila. Abathungi abaningi bemithi yokwelashwa okunye bayayesaba lokho okwesaba ngokwemvelo, futhi ngokuphelelwa yisikhathi iziguli eziningi zamukela indlela yokudubula, ziqukethe izinto eziningi zemithi ezisekelwe ezitatimendeni ezingenakulinganiswa ezivela kumenzi.
Le ndlela "yokubamba-konke-off-the-shelf" ingaba yabiza futhi ngezinye izikhathi ayiphumeli.
Imithi eminingi yokwelapha yomdlavuza we-prostate ayinabungozi, kepha isithembiso sabo sokuthuthukisa impilo ende siyiqiniso. Okunye okubheka ukuthi izimangalo eziningi ezivela embonini enkulu yokusiza zingasiza, kanye nokucubungula kwezinye izinto, izimangalo ezisebenzayo eziningi zemithi ethile engavamile ukubhekwa ngomsebenzi wabo wokulwa ne-antiticancer.
Ukuhlola izimangalo
Lapho sifuna ukwelashwa okuphumelelayo, singayahlukanisa kanjani ukolweni kumakhoba? Phela, indlela yokudubula inomkhawulo: asikwazi ukunqanda izinqwaba zamaphilisi unyaka nonyaka ngaphandle kokuqinisekiswa kobufakazi besayensi. Kufanele kube khona indlela yokuhlunga ngaleyo nsimu enkulu yabalingani kanye nomhlaba kuma-agent asebenzayo kakhulu.
Eminyakeni engama-20 ngisebenza neziguli zomdlavuza we-prostate, ngiye ngafunda izimiso ezimbalwa ezinokwethenjelwa ukuze ngisize le nkinga.
- Kubalulekile ukuhlukanisa ubufakazi obukhona besayensi ezivela ezindabeni ezithakazelisayo eziphekwe yiminyango yokumaketha. Abathengisi bahlola zonke izinhlobo zezinkomba ezithakazelisayo mayelana nokuthi, isibonelo, umkhiqizo wabo uvuselela amasosha omzimba. Lesi yisimangalo esihle semithi yemifino ngoba ayikho indlela yokukala ngokuqondile ukuzivikela komzimba ngakho-ke akukho ndlela yokuphikisa izimangalo.
Imithi ye- immune yangempela igunyazwa yi-FDA ngokubonisa ukuthi iqhubeka isinda isikhathi eside. Ngeshwa, imithetho enjalo enamandla ayisetshenziselwa imboni yokuxhaswa. Izinkampani ezithengisa imikhiqizo ye-herbal ayidingekile ukufakazela noma yini kunoma ubani.
- Into yesibili okufanele uyikhumbule uma ucabangela i-ejenti engabhaliswanga ukukhipha isaphulelo ngokuphelele ngokusebenza ngokusekelwe ezenzweni ezenziwe nezilwane. Lezi zifundo nje azihumushi kubantu. Isikhathi nesikhathi futhi, imiphumela emihle iye yafezwa okokuqala kuma rats kuphela ukufakazela ukuthi awunalutho uma ubuyiselwa kubantu. Uma izifundo eziyimpumelelo ziyimpumelelo ye-anticancer effecti, izinkinga zethu zomdlavuza ngabe ziphuluke eminyakeni edlule.
- Okokugcina, angikaze ngibone i-agent e-antiticancer esebenzayo engenazo imiphumela emibi ngokuphelele. Noma yini enamandla ngokwanele yokulwa nomdlavuza ingenaso njalo okungenani eminye yemiphumela emibi. Ama-agent anephrofayili yempembelelo yomsindo ophelele angabhekwa njengento engenamsebenzi ngokumelene nomdlavuza.
Ngeshwa, lezi zimiso ezintathu ziholela esiphethweni esiphezulu sokuthi akukho nesisekelo sokusebenzisa imali kuma-herbal agents ukulwa nomdlavuza.
Imiphumela Yokudla
Njalo lapho indaba yokwelashwa okunye ivela ngaphansi kwengxoxo, kungokwemvelo ukuthi imibuzo iphakame mayelana nomthelela wokudla.
Njengoba umsebenzi wami ukhula, ngabona iziguli eziningi zivimbela i-PSA yazo ngokunamathela ezidlweni ezinamandla ezinama-vegan noma macrobiotic. Ukukholelwa kwami ekubalukeni kokudla kwaqinisekiswa nakakhulu lapho uT. Colin Campbell enyathelisa incwadi ebizwa ngokuthi i-China Study eyabonisa ukuxhumana okuqinile phakathi kwamaprotheni ezinyukayo ezikhulayo kanye namaphesenti aphezulu emdlavuza.
Ukudla kungenza kanjani umthelela omkhulu? Asinazo zonke izimpendulo, kodwa kunamaphuzu athile okunengqondo. Okokuqala, cabanga ukuthi okuyinhloko yalokho okwenza umdlavuza kuyingozi ukuphindaphinda kwamaselula nokukhula komzimba. I-Cancer iba yingozi ngenxa yokwehlisa izicubu ezithwala umzimba obangela ukungasebenzi komzimba, okuyinto ekugcineni kuholela ekudleni kwesiguli.
Akunengqondo yini ukucabanga ukuthi izicubu "ezondliwe kahle" ziyokhula ngokushesha kunalokho ezondla ngokudla? Ukudla okuphezulu emaprotheni wesilwane kukhuthaza ukukhula kwamaselula ngoba kunika amandla amaningi ama-amino acids, izakhiwo eziyisisekelo zamangqamuzana omdlavuza omusha. Iprotheyini yezilwane nayo iqukethe amafutha amakhulu, umthombo onamandla wamandla eselula. I-hamburger "enomzimba", isibonelo, iqukethe ama-50 amaphesenti amafutha, ngakho-ke amaprotheni wesilwane angaba ngumlilo emlilweni womdlavuza.
Ngakolunye uhlangothi, ukudla okunomdlavuza kungcono kakhulu ukuvimbela umdlavuza. Ngeshwa, abantu abambalwa kuphela abanokuzibophezela okudingekayo ukuze baqhubeke nokudla kwe-vegan esikhathini eside.
Kodwa enye, mhlawumbe ukhetho olungcono kakhulu lukhona. Imithi ethile yemithi ingasetshenziswa njengendlela yokwelashwa okunye. Ama-agent amabili, ama-statins kanye ne-metformin, abonakala sengathi afinyelela imiphumela yabo ye-anticancer ngokulingisa imiphumela yokudla kwe-vegan.
I-Metformin
I-Metformin iyi-generic imithi evunyelwe ukwelashwa kwesifo sikashukela . Ucwaningo olwenziwe ngokucophelela lwenziwe ukuhlola izinga lokusinda kubantu abesifo sikashukela kanye nomdlavuza wesicathulo abaphathwa nge-metformin. Lapho izinga lokusinda lamadoda aphethwe yi-metformin liqhathaniswa nezinye iziguli ezinezifo zesifo sikashukela nomdlavuza futhi ziphathwa ngemithi ngaphandle kwe-metformin, amadoda aphethwe yi-metformin aphila isikhathi eside.
Impumelelo ye-Metformin ye- anticancer iyabonakala ngokucacile ngomphumela wayo wokunciphisa i-insulin. I-insulin ephezulu ayibi ngenxa yeziguli zomdlavuza ngoba i-insulin inemisebenzi efana ne-hormone yokukhula. Ukugcina amazinga e-insulini egazini elisezingeni eliphansi ngokudla okunempilo, metformin, noma kokubili kunciphisa ukuvuthwa kwe-hormonal yokukhula komdlavuza.
Izitatimende
Izitatimende, okunye okubizwa ngokuthi amaphilisi e-cholesterol, ingenye uhlobo lwemithi ebonakala ilinganisa imiphumela enenzuzo yokudla kwe-vegan. Embikweni owethulwe nguDkt Park emhlanganweni waminyaka yonke we-American Urology Association ngo-2015, amazinga omuthi we-prostate we-prostate akholelwa ukuthi amaphesenti angu-25 angcono uma amadoda athatha amaphilisi e-cholesterol.
Ukuthola kwakhe kwakusekelwe ekuhloleni kwezifundo eziyishumi nesikhombisa ezihlanganisa iziguli ezingama-30,000. Eziyisikhombisa zalezi zifundo zahlola amadoda aphethwe ngama-radiation, amadoda ayisishiyagalolunye ahlolwe ngokuphathwa, kanti omunye wahlola inhlanganisela yalaba ababili. Ngesizathu esithile, amazinga okuphulukiswa okuphuculwe abonakala kuphela emadodeni aphathwa ngemisebe.
Ukuthola okufanayo kwabikwa uDkt Grace L. Lu-Yao ngo-2015 emhlanganweni wonyaka we-American Society of Clinical Oncology. Ekutadisheni kwakhe iziguli ezingama-22,110 zomdlavuza we-prostate, imithi yesimiso esisetshenziswa ngokuhlanganyela ne-metformin inciphise ingozi yokubulawa komdlavuza ngamaphesenti angu-43.
Aspirin
I-aspirin iyimithi yesithathu ukuthi iziguli zomdlavuza we-prostate kudingeka zicatshangelwe. Nakuba i-aspirin inobuningi futhi iyaziwa kakhulu ukunciphisa ukuhlolwa kwengozi yenhliziyo ibonisa ukuthi inciphisa ingozi yokuhlaselwa yinhliziyo ngamaphesenti angu-30-izihloko ezimbili ezishicilelwe embikweni we-Journal of Clinical Oncology kubika imiphumela ephawulekayo ye-anticancer.
Ngomhla ka-Oktoba 2012, uDkt. Kevin Choe wabika ukuthi izinga lokufa komdlavuza we-prostate wonyaka eyishumi lancishisiwe kusuka kumaphesenti angu-19 kuya ku-4% emadodeni athatha aspirin uma eqhathaniswa nalabo abangazange bawenze. Esinye isihloko esashicilelwe ngo-2014 nguDkt. Eric Jacobs sabuye sahlola ukubaluleka kwe-aspirin ye-dose ephansi. Kulesi sifundo, izinga lokufa komdlavuza wesifo sofuba lwangumaphesenti angama-40 aphansi emadodeni aphathwa yi-aspirin uma kuqhathaniswa namadoda angathathi aspirin.
Izinketho ze-OTC
Amanxusa amaningi angaphezu kwe-anti-herbal ayinabungozi. Kodwa-ke, lokhu akuyona yonke into eqinisweni. Ucwaningo olushicilelwe luye lwaphakamisa ukukhathazeka ukuthi ama-multivitamini angase "akondle" umdlavuza, okuholela ekusindeni okufishane kweziguli zomdlavuza we-prostate. Ucwaningo lubuye lwabika ukuthi ukudliwa ngokweqile kwamaminerali athile kungase kube nomthelela ofanayo.
Isibonelo, izifundo zamadoda ezithatha inqwaba ye-zinc ne-iron umbiko wokuphila okufutshane. Ngicabanga ukuthi incazelo yemiphumela emibi yama-multivitamine namaminerali awela emigqeni yalokho okubonwayo nge-high protein diet. Njengalapho abantu bedla ama-amino acide ngokweqile okuholela ekukhuleni komdlavuza okusheshayo, izikhumba zikhula ngokushesha uma zinikezwa inani eliningi lamavithamini namaminerali.
Izingozi Zokucabangela
Ngenkathi ukuhlolwa kwe-aspirin, i-metformin, kanye nezidakamizwa ze-statin kubonakala sengathi kuzuzisa, akuyona ingozi. Nge-aspirin, isibonelo, umuntu oyedwa kwabangu-200 angathola isisu sesisu esisisu . Abantu abathatha i-aspirin abahlakulela izitshalo ezimnyama noma ukukhwabanisa kufanele bayeke ngokushesha futhi bathole ukwelashwa okwengeziwe.
Imiphumela emibi engaba khona evela ezidakamizweni ze-statin ihlanganisa izinhlungu ze-muscle nezinkinga zesibindi. Ngemuva kokuqala isiteji, amadoda kudingeka axwayiswe ukuba ayeke imithi uma izinhlungu zomzimba ezintsha zikhula. Ukuhlolwa kwegazi ukuthola ukuthi yikuphi ukukhubazeka kwesibindi kuyadingeka.
Imiphumela emibi ye-metformin ivame ukulingana nokungazinzi kahle kwamathumbu emathunjini. Kodwa-ke, i-metformin kufanele isetshenziswe ngokuqapha kumadoda amadala anomsebenzi wezinso okhubazekile.
Kungenzeka ukuthi uzizwe ululama ngokuthatha imishanguzo "eyengeziwe", mhlawumbe ngenxa yokukhathazeka ngemiphumela emibi. Kodwa kunezindlela zokunciphisa lezi zingozi.
- Ukuqapha nokuvame ukuhlolwa kwegazi kufanele kube yinto evamile lapho kunqalwa imithi emisha. Ngale ndlela, uma kwenzeka inkinga ehlobene nemithi, ingatholakala ngokushesha futhi imithi ingamiswa ngaphambi kokuba kube khona ukulimala okuhlala njalo.
- Ukuqala imithi engaphezu kweyodwa ngesikhathi esisodwa kufanele kugwenywe. Khona-ke, uma imiphumela emibi ivela, ukudideka ngokuthi yiyiphi i-agent ekhubazayo igwenywe.
- Imithi emisha kufanele iqaliswe esilinganisweni esincane. Ukwehla kwesisu kufanele kwenziwe kancane kancane futhi emva kokubekezelela okuqinisekisiwe kuqinisekiswa kumthamo ophansi.
Naphezu kwesidingo sokuqapha okuthile, i-aspirin, amaphilisi e-cholesterol, kanye ne-metformin kubonakala sengathi inezinzuzo ezinkulu ze-antiticancer kubantu abane-cancer yomzimba. Le mithi ayithengi futhi ayifinyeleleke kalula, ngakho kubonakala kuhlakaniphile kubantu abanomdlavuza we-prostate ukuxoxa ngokuthi kungenzeka yini ukuqala i-aspirin, i-metformin nesimiso esinezidakamizwa.
Izwi elivela
Ngenkathi isisindo semithi esithengiswa kahle kakhulu singase sijabulise, kungase kungabi yindlela engcono kakhulu yokulwa nomdlavuza wakho. Kuyacaca ukuthi izifundo ezibonisa ukunamathela okunamandla ekudleni okuncane ezithombeni zamaprotheni yizinto ezikholisa kakhulu. Kodwa-ke, izinzuzo ezengeziwe "zokudla" ze-metformin ne-cholesterol amaphilisi akumelwe zikhohlwe, futhi akufanele futhi izinzuzo ze-aspirin. Uma ucabanga ukuthi uqapha ngokucophelela ngokumelene nemiphumela emibi, lezi zinhlaka ezintathu zizuzisa kakhulu kunokulimaza.
> Imithombo:
> Campbell, T. Colin, noThomas M. Campbell, II. I-China Study: Isifundo Esiyinkimbinkimbi Esiyinkimbinkimbi Sokudla Konke Esike senziwa kanye Nethonya Lokuqala Lokudla, Ukulahlekelwa Isisindo, Nempilo Yesikhathi Eside . Amabhuku we-BenBella wokuqala ahleliwe. Dallas, I-Tex .: BenBella Books, 2005.
> Park, HS, JD Schoenfeld, RB Mailhot, M. Shive, RI Hartman, R. Ogembo noLa Mucci. "Izitatimende kanye nesifo somdlavuza we-prostate ngokulandela i-prostatectomy enkulu noma i-radiotherapy: ukubuyekezwa okuhlelekile nokuhlaziywa kwe-meta." Ama-Annal of Oncology 24, cha. 6 (2013): 1427-1434.
> Lu-Yao, Grace L., Yong Lin, Dirk Moore, John Graff, Antoinette Stroup, Kimberly McGuigan, uStephen Crystal, uShahla Amin, uKitaw Demissie noRobert S. DiPaola. "I-statin / metformin yokuhlanganiswa nokufa komdlavuza othize nge-prostate: Ucwaningo oluthile lwabantu." (2015): 5018-5018.
> Jacobs, Eric J., Christina C. Newton, Victoria L. Stevens, Peter T. Campbell, uStephen J. Freedland noSusan M. Gapstur. "Ukusetshenziswa kwe-aspirin yansuku zonke kanye nokufa kwesifo somdlavuza we-prostate eqenjini elikhulu lamadoda anomdlavuza we-prostate ongapheli." I-Journal of Clinical Oncology 32, no. 33 (2014): 3716-3722.